This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics Systems. This report contains market size and forecasts of Molecular Diagnostics Systems in global, including the following market information:
- Global Molecular Diagnostics Systems Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global Molecular Diagnostics Systems Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Molecular Diagnostics Systems companies in 2022 (%)
The global Molecular Diagnostics Systems market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
PCR Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Molecular Diagnostics Systems include Abbott Laboratories, Qiagen N.V., Roche Diagnostics, Hologic, Inc., Grifols, Siemens Healthcare, Becton, Dickinson and Company, Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) and Biom?rieux Sa, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Molecular Diagnostics Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Diagnostics Systems Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Molecular Diagnostics Systems Market Segment Percentages, by Type, 2022 (%)
- PCR
- Hybridization
- DNA Sequencing
Global Molecular Diagnostics Systems Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Molecular Diagnostics Systems Market Segment Percentages, by Application, 2022 (%)
Global Molecular Diagnostics Systems Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Molecular Diagnostics Systems Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Molecular Diagnostics Systems revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Molecular Diagnostics Systems revenues share in global market, 2022 (%)
- Key companies Molecular Diagnostics Systems sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Molecular Diagnostics Systems sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- Qiagen N.V.
- Roche Diagnostics
- Hologic, Inc.
- Grifols
- Siemens Healthcare
- Becton, Dickinson and Company
- Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
- Biom?rieux Sa
- Cepheid Inc
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Molecular Diagnostics Systems, market overview.
- Chapter 2: Global Molecular Diagnostics Systems market size in revenue and volume.
- Chapter 3: Detailed analysis of Molecular Diagnostics Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Molecular Diagnostics Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Molecular Diagnostics Systems capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
